Acer Medical (ROCO:6857) Research & Development: NT$29.94 Mil (TTM As of Dec. 2025)


ROCO:6857 Acer Medical Inc ROCO:6857
52 GF Score
Price NT$93.90
GF Value NT$261.37
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Acer Medical Research & Development?

Acer Medical ROCO:6857 52 Research & Development is NT$29.94 Mil as of Dec. 2025. GuruFocus rates ROCO:6857 with a GF Score™ of 52/100 and a GF Value™ of NT$261.37 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Acer Medical's Research & Development for the six months ended in Dec. 2025 was NT$14.56 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$29.94 Mil.

Acer Medical  (ROCO:6857) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Acer Medical Research & Development Related Terms

Acer Medical Research & Development Historical Data

* Premium members only.

The historical data trend for Acer Medical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acer Medical Research & Development Chart

Acer Medical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 13.63 26.30 20.54 26.85 29.94

Acer Medical Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.90 13.54 13.30 15.38 14.56
ROCO:6857
52GF Score
Acer Medical Inc ROCO:6857
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acer Medical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$29.94 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$29.94 Mil mean?
Acer Medical (ROCO:6857) has a Research & Development of NT$29.94 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Acer Medical and its competitors.
Is Acer Medical's Research & Development too high?
Acer Medical's current Research & Development is NT$29.94 Mil. Overall, Acer Medical has a GF Score™ of 52/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acer Medical's Research & Development compare to VEEV and BTSG?
Acer Medical's Research & Development of NT$29.94 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Acer Medical and its competitors. Acer Medical's current Research & Development is NT$29.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acer Medical stock overvalued right now?
Based on GuruFocus' analysis, Acer Medical (ROCO:6857) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$261.37, compared to a current price of NT$93.90 — trading 64.1% below its estimated fair value. The current Research & Development is NT$29.94 Mil. Acer Medical's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Acer Medical (ROCO:6857), the current Research & Development is NT$29.94 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acer Medical (ROCO:6857) Overvalued in 2026?

Based on GuruFocus' analysis, Acer Medical stock appears to be undervalued. The current stock price of NT$93.90 is trading 64.1% below its estimated GF Value™ of NT$261.37. GuruFocus considers Acer Medical to be Significantly Undervalued.

Key valuation signals for ROCO:6857:

  • Research & Development: NT$29.94 Mil
  • GF Value™: NT$261.37 vs. price of NT$93.90 (64.1% below fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6857 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Acer Medical Business Description

Address Xintai 5th Road, 7th Floor, No. 86, Section 1, Xizhi District, New Taipei, TWN
Acer Medical Inc focuses on improving human health and well-being through artificial intelligence. It focuses on applying artificial intelligence and large data to the area of healthcare. Acer Medical is capable of designing, developing, commercializing, as well as implementing AI solutions in medical institutions.
52GF Score

Get the complete analysis for ROCO:6857

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$93.90
Price
NT$261.37
GF Value